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Abstract: The role of surgically removing subcutaneous fat by abdomino-
plasty on circulating inflammatory markers and myocardial dysfunction,
evaluated by myocardial performance index (MPI), were investigated.
Twenty volunteers submitted to the abdominoplasty (abdominoplasty group),
and other 28 women treated by hypocaloric diet (diet group) were evaluated.
Echocardiographic parameters of MPI, circulating levels of tumor necrosis
factor (TNF)- and interleukin (IL)-6, were performed at baseline and 2
months later. Compared with nonobese women, obese women had increased
concentrations of TNF- (P  0.01), IL-6 (P  0.01), and higher MPI (P 
0.02), indicating ventricular dysfunction. Subcutaneous fat concentrations of
TNF- and IL-6 were related to MPI impairment. After 60 days, waist-to hip
ratio was significantly reduced in the abdominoplasty group. Anthropometric
changes were accompanied by a significant decline in plasma concentrations
of TNF- and IL-6 levels as well as by significant improvements of MPI in
abdominoplasty group compared with diet group. Abdominoplasty may
represent a safe method for ameliorating cardiac function in obese women.
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Many studies show that in obese patients heart contractiledysfunction is associated with increased body fat and partic-
ularly visceral fat.1 A likely mechanism for this association may be
through plasma cytokine levels, which correlated with myocardial
performance index (MPI), a useful method to estimate heart func-
tion, both at baseline and after sustained weight loss.2 Indeed,
circulating mediators of inflammation participate in the mechanisms
of myocardial damage,3,4 and many of these inflammatory proteins
are secreted directly from adipocytes and adipose tissue-derived
macrophages: adipose tissue synthesize and secrete several cyto-
kines, including tumor necrosis factor (TNF)-5 and interleukin
(IL)-6.6 Elevated levels of TNF- and IL-6 have been found to be
associated with proxy indicators of elevated body fat7 and with risk
of heart failure.8,9 The progressive increase in adipose tissue, pro-
duced by long-term disequilibria in energy balance, may evoke these
pro-inflammatory properties of adipocytes as well as adipose tissue-
derived macrophages.10 Prior literature has emphasized the impor-
tant relations of visceral adiposity with inflammation and related
cardiometabolic risk, whereas recent data show that both subcuta-
neous and visceral adipose tissues appear to be associated with
chronic inflammation.11 Therefore, as subcutaneous adipose tissue
may have multiple metabolic and endocrinologic properties that
have previously been ascribed only to visceral adipose tissue,11 we
thought that a surgical massive excision of these “pathologic” fat
cells through abdominal dermolipectomy could be able to ameliorate
the inflammatory pattern as well as cardiac function in patients with
visceral obesity. Although metabolic benefits of abdominal liposuc-
tion on cardiovascular system, insulin sensitivity and diabetes are
controversial,12,13 no study has evaluated the possibility that mas-
sive excision of abdominal fat tissue through abdominal dermoli-
pectomy may affect the inflammatory state and cardiac function in
obese patients. Therefore, the aim of the present study was to
evaluate whether myocardial dysfunction, evaluated by MPI, was
associated with proinflammatory cytokines produced by subcutane-
ous adipose tissue in premenopausal obese women. Moreover, the
role of surgically removing subcutaneous fat by abdominoplasty on
circulating inflammatory markers as well as on cardiac function was
also investigated and compared with the effects of 2 months of
hypocaloric diet intervention.
RESEARCH DESIGN AND METHODS
We reviewed clinical data and echocardiograms for 48 obese
women who had standard indications for abdominoplastic surgery.14
Twenty obese women who had volunteered to undergo abdomino-
plastic surgery were included in the abdominoplasty group of this
study; further 28 obese patients without surgical obesity treatment
were included in the diet group (Fig. 1). Nonobese (body mass index
BMI 25) healthy women matched for age to obese women
served as control group. All study groups volunteered for repeated
clinical evaluations and laboratory analyses as well as echocardiog-
raphy. In the abdominoplasty group, for avoiding the confounding
effect of abdominoplasty-related changing in body weight in the
follow-up period, a weight-maintaining diet consisting of 55%
carbohydrates, 30% lipid, and 15% protein was administered for 2
months on an outpatient basis. In the diet group, women were treated
with a multidisciplinary approach consisting of diet, exercise, and
behavioral and nutritional counseling. The mean recommended daily
caloric intake was 1300 kcal, ranging from 1250 to 1350 kcal. The
recommended composition of the dietary regimen was 55% carbo-
hydrates, 30% lipid, and 15% protein, and were followed on an
outpatient basis until 2 months This regimen was very similar to the
Mediterranean-Style step I diet.15 All obese women were sedentary
(1 h/wk of physical activity), with no evidence of participation in
diet reduction programs within the last 6 months. Women were
excluded from the study if they had type 2 diabetes, hypertension,
cardiovascular disease, psychiatric problems, a history of alcohol
abuse, or if they smoked or took any medication. All women had
normal results for laboratory data (urea nitrogen, creatinine, elec-
trolytes, liver function tests, uric acid, thyroxin, and complete blood
count), chest x-rays, and electrocardiograms. All women had
Received September 2, 2008, and accepted for publication, after revision, No-
vember 15, 2008.
From the *Department of Geriatrics and Metabolic Diseases, Second University
of Naples, Italy; †Plastic and Reconstructive Surgery, Second University of
Naples, Naples, Italy; and ‡Department of Clinical, Public and Preventive
Medicine, Second University of Naples, Italy.
Reprints: Raffaele Marfella, MD, PhD, Piazza Miraglia, 2, Naples, Italy 80138.
E-mail: raffaele.marfella@unina2.it.
Copyright © 2009 by Lippincott Williams & Wilkins
ISSN: 0148-7043/09/6305-0490
DOI: 10.1097/SAP.0b013e3181955cdb
Annals of Plastic Surgery • Volume 63, Number 5, November 2009490 | www.annalsplasticsurgery.com
normal glucose tolerance (2-hour postload plasma glucose 7.4
mmol/L) and were studied in the same phase of the menstrual
cycle. All women were studied after a 14-hour overnight fast and
were required to refrain from drinking alcohol over the previous
10 days. All women were evaluated at baseline and 2 months
later.
Anthropometrics Parameters
Women were measured to the nearest 0.5 cm in height and
100 g in weight. Height was determined with the subject standing
without shoes and weight with the subject in stockinged feet, using
a mechanical scale. BMI was calculated as weight in kilograms
divided by the square of height in meters. Waist-to hip ratio (WHR)
was calculated as waist circumference in centimeters divided by hip
circumference in centimeters.
Echocardiography
All women underwent 2-dimensional and Doppler echocar-
diography, with measurements taken according to the American
Society of Echocardiography recommendations.16 Only frames with
optimal visualization of interfaces and simultaneously showing
septum, left ventricular internal diameter, and posterior wall were
used for reading. Two observers read the tracings, and the mean
value from at least 5 measurements per observer were computed.
The readers of the echo were blinded. Left ventricular mass was
calculated according to Troy et al17 and was normalized by both
body surface area and height18 to correct for the effect of over-
weight. The ejection fraction was calculated from area measure-
ments using the area-length method applied to the average apical
area.19 MPI was measured as previously described.20 Doppler ve-
locities and time intervals were measured from mitral inflow and left
ventricular outflow recordings. Isovolumetric relaxation time (IRT)
was the time interval from cessation of left ventricular outflow to
onset of mitral inflow. ET was the time interval from the onset and
cessation of left ventricular outflow, and mitral early diastolic flow
deceleration time was the time interval between the peak early
diastolic velocity and the end of early diastolic flow. Total systolic
time interval was measured from the cessation of one mitral flow to
the beginning of the following mitral inflow. Isovolumetric contract-
ing time (ICT) was calculated by subtracting ET and IRT from the
total systolic time interval. The ratio of velocity time intervals of
mitral early and late diastolic flows was calculated. MPI was
calculated by using the formula MPI  (IRT  ICT)/ET.20,21
Analyses of Blood Samples
Serum samples for cytokine levels were stored at T 80°C
until assayed. Serum concentrations of TNF- and IL-6 were deter-
mined in duplicate using a highly sensitive quantitative sandwich
enzyme assay (Quantikine HS; R&D Systems, Minneapolis, MN).
Assays for serum total and high-density lipoprotein cholesterol,
triglyceride, and glucose levels were performed in the hospital’s
chemistry laboratory. Plasma insulin levels were assayed by radio-
immunoassay (Ares, Serono, Italy). Insulin resistance in the fasting
state was assessed with homeostasis model assessment (HOMA) and
calculated with the following formula: fasting plasma glucose (mil-
limoles per liter) times fasting serum insulin (microunits per milli-
liter) divided by 25, as described by Matthews et al.22
Abdominal Dermolipectomy
Patients underwent conventional abdominoplasty surgical
procedure, with umbiliculum transposition and cutaneous adipose
mass tissue excision ranging from 2878  200 gr. Patients were
mobilized 24 hours after surgery, anti-inflammatory therapy
(nonsteroidal anti-inflammatory drugs) was suspended after 48
hour and were discharged 72 hours following with antibiotic
therapy.
Analyses of Adipose Tissue
After surgery, the specimens were cut parallel to the long axis
into 2 halves. The first half was frozen in liquid nitrogen for the
following enzyme-linked immunosorbent assay analysis. A portion
of the other half specimen was immediately immersion fixed in 10%
buffered formalin. Sections were serially cut at 5 m, mounted on
lysine-coated slides, and stained with hematoxylin/eosin and with
the trichrome method. Specimens were analyzed by light microscopy.
Biochemical Adipose Tissue Assays
Specimens were lysed and centrifuged for 10 minutes at
10,000g at 4°C. After centrifugation, 20 g of each sample were
analyzed for quantification of IL-6 and TNF- levels using a specific
enzyme-linked immunosorbent assay kits (Santa Cruz).
Immunohistochemistry
After the surgical procedure, samples were immediately fro-
zen in isopentane and cooled in liquid nitrogen. Serial sections were
incubated with specific antibodies antinitrotyrosine and anti-CD68
(Dako), anti–TNF-, anti-IL-6 (R&D).
Analysis of immunohistochemistry was performed with a
personal computer–based quantitative 24-bit color image analysis
system (IM500, Leica Microsystem AG).
Each woman provided informed written consent to participate
in this study, which was approved by the institutional committee of
ethical practice of our institution. The patients subscribed a separate
informed consent to undergo abdominoplasty.
FIGURE 1. Study protocol.
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Statistical Analysis
Data are presented as group means  SD. One-way analysis
of variance (ANOVA) was used to compare baseline data, followed
by Scheffes test for pairwise comparisons. Multiple comparisons
were made with ANOVA, followed by post hoc analysis (Student-
Newmann-Keuls test) to locate the significant difference indicated
with ANOVA. Simple and partial correlation were used to evaluate
relationships between variables. A value of P 0.05 was considered
significant. All calculations were made on an IBM PC (version 12.0;
SPSS, Chicago, IL).
RESULTS
The characteristics of study groups are shown in Table 1. The
mean age was similar among the obese and nonobese groups, and
BMI and WHR were significantly higher in the obese group.
Compared with nonobese women, obese women had higher fasting
glucose and insulin concentrations and HOMA scores. As expected
for an obese female population, serum TNF- (P  0.01) and IL-6
(P 0.01) levels were higher than those of nonobese women (Table
1). Serum cytokine levels and HOMA scores were related to mea-
sures of total (BMI) and, particularly, central (WHR) obesity (Table
2). Echocardiographic/Doppler measurements are presented in Table
1. Compared with nonobese women, all obese women had longer
left ventricular internal diastolic diameter (P  0.01), thicker inter-
ventricular septum (P  0.05), and left ventricular posterior wall
(P  0.04), but lower ejection fraction (P  0.05) (Table 1).
Moreover, obese women had higher MPI (P  0.02), indicating
ventricular dysfunction (Table 1). Measures of total and central
adiposity were inversely related to ejection fraction, and directly
related to MPI (Table 2). Concentrations of TNF- and IL-6 were
inversely related to ejection fraction, and directly related to MPI
(Table 2). Before abdominoplastic surgery and diet, there were
no significant differences in all study parameters between ab-
dominoplasty and diet obese groups (Table 3). After abdomino-
plasty, the mean fat tissue removed was 3.2 kg. A great portion
of adipose tissue was occupied by macrophages, as well as both
immunohistochemistry and quantitative analyses revealed high
staining and levels of TNF- and IL-6 (Fig. 2). Notably, adipose
tissue concentrations of TNF- and IL-6 were directly related to
MPI (Fig. 2).
Cardiovascular Effects of Abdominoplasty
Two months after both abdominoplastic surgery or diet pro-
gram, BMI was significantly reduced in both abdominoplasty and
diet groups, without significant differences between the groups,
while WHR was significantly reduced only in the abdominoplasty
group (Table 3). A significant and similar decline in fasting plasma
insulin, plasma triglycerides and HOMA scores were observed in
both groups (Table 3). Serum total cholesterol, cholesterol subfrac-
tions, and fasting plasma glucose values were unaffected after the
same period in both groups (Table 3). In contrast inflammatory
pattern (plasma TNF- and IL-6 levels) as well as in echocardio-
graphic parameters (MPI, ejection fraction) were significantly im-
proved in abdominoplasty group either versus baseline condition or
versus diet treated obese group at the end of the same follow-up
period (60 days) (Table 3). In addiction changes in inflammatory
patterns were also related to decline in WHR (Table 4). Interestingly
enough, changes in WHR correlated with improvements in cardiac
function (MPI, ejection fraction) (Table 4). Such correlation was lost
after adjustment for BMI. In nonobese women, anthropometric,
metabolic, and echocardiographic parameters were not different
from baseline after 60 days (data not shown).
CONCLUSIONS
The main findings of this study are that MPI, an index of heart
dysfunction, positively correlated with proinflammatory cytokine
levels in subcutaneous fat tissue and that surgically removing
subcutaneous fat by abdominoplasty resulted in significant improve-
ment of the sequelae of ventricular dysfunction evidenced by MPI.
Such improvements are mainly associated with a significant decline
in circulating pro-inflammatory cytokines. Because any associated
conditions could be ruled out through clinical investigation and
close laboratory evaluation, it is reasonable to hypothesize that in the
clinical setting, any changes in cardiac function can be interpreted as
a consequence of massive excision of fat cells through abdominal
abdominoplastic surgery.
TABLE 1. Clinical Characteristics of the Obese Women
(Abdominoplasty Group  20; Diet Group  28) and
Nonobese Women
Obese Women Nonobese Women
n 48 20
Age (yr) 40.5  5 39  5
BMI (kg/m2) 33.8  3.1* 23.8  1.8
WHR 0.90  0.01* 0.79  0.04
Systolic blood pressure (mm Hg) 117.3  4.1 117.8  5.2
Diastolic blood pressure (mm Hg) 80.2  3.3 78.9  3.9
Fasting glucose (mmol/L) 5.3  0.3* 4.8  0.4
Fasting insulin (U/mL) 16.7  4.8* 7.9  2.5
HOMA 3.6  0.5* 1.6  0.4
Total cholesterol (mmol/L) 5.1  0.4 5.0  0.6
LDL cholesterol (mmol/L) 3.0  0.3 3.2  0.3
HDL cholesterol (mmol/L) 1.1  0.2 1.1  0.3
Triglyceride (mmol/L) 1.4  0.5 1.4  0.5
TNF- (pg/mL) 6.1  1.8* 2.2  0.7
IL-6 (pg/mL) 4.1  0.7* 2.5  0.9
LVM/BSA (g/m2) 95.1  13* 71.8  12
LVM/h2 (g/m2) 64.6  7* 46.9  9
IVS (mm) 11.1  1.4* 8.3  1.0
MPI 0.57  0.05* 0.35  0.05
Ejection fraction (%) 51  5* 65  8
Data are group means  SD.
*P  0.05 compared with nonobese women.
IVS indicates interventricular septum; LVM/BSA, left ventricular mass index/body
surface area; LVM/h2, left ventricular mass index/height squared.
TABLE 2. Relationships of Anthropometric Measures of
Obesity and Concentrations of Proinflammatory Cytokines
With Echocardiographic Parameters in Obese Women
BMI WHR TNF- IL-6
TNF-* 0.28† 0.43‡ — 0.10
IL-6* 0.38‡ 0.55§ 0.10 —
HOMA 0.33‡ 0.53§ 0.36‡ 0.29†
Ejection fraction 0.10 0.38‡ 0.36‡ 0.28†
MPI 0.12 0.37‡ 0.36‡ 0.26†
Measures of total and central adiposity as well as proinflammatory cytokines were
inversely related to ejection fraction, and directly related to MPI.
*Log transformed.
†P  0.05.
‡P  0.02.
§P  0.01.
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Studies have identified MPI as an independent predictor
cardiac mortality in patients with heart failure.23 Obesity is associ-
ated with an increased risk of developing heart failure, irrespective
of the presence of other associated risk factors, such as hypertension,
hyperlipidemia, hyperinsulinemia, diabetes, elevated alcohol con-
sumption, and smoking.1 Many of these associated factors were, by
inclusion criteria, not present in our population of obese women; this
seems to suggest that the morphologic and functional echocardio-
graphic alterations are due to obesity. The increase of MPI indicates
a worse functional outcome in obese women. MPI is a Doppler
index of combined systolic and diastolic function24 derived from
aortic and mitral flows and has been shown to be related to
morbidity and mortality in patients with various cardiovascular
disorders, including heart failure.20,21 The present study provides
evidence of an association between MPI abnormalities and subcu-
taneous abdominal fat in obese women. As for the background of
this association, obesity may be responsible for an increased inflam-
matory process and a poor cardiac contractile function may be
linked to a greater inflammatory process in the subcutaneous fat.
More than 25 years ago, Lefer and Rovetto25 reported that the sera
of septic patients and experimental animals contained a “myocardial
depressant factor,” the molecular nature of which has eluded defin-
itive identification in the intervening years. During the past decade,
TNF- and IL-1 were shown to be present in the sera of septic
patients and responsible for most, if not all, of the reversible cardiac
depression often seen with this syndrome.26 These data are consis-
tent with earlier reports27 that soluble inflammatory mediators in
medium conditioned by activated immunocytes altered the contrac-
tile responsiveness of beating cardiac muscle cells to beta-adrener-
gic agonists, an effect that could be mimicked in this in vitro
preparation by recombinant TNF- or IL-1. Accordingly, the
subcutaneous fat concentrations of TNF- and IL-6 were positively
related to MPI and negatively related to ejection fraction. All of this
seems to suggest that cytokines elaborated by subcutaneous adipo-
cytes and macrophages may be partly responsible for cardiac dys-
function observed in obese women. The present finding underscores
the positive association of abdominal subcutaneous adipose tissue
with circulating markers of inflammation. Although prior literature
has emphasized the important relations of visceral adiposity with
inflammation and related cardiac dysfunction,28 the role of subcu-
taneous fat are not yet completely characterized. However, recent
research has shown that both visceral and subcutaneous adipose
tissue are related to markers of inflammation and oxidative stress.11
Moreover, a very recent data suggest that adipose tissue macro-
phages may be active players in the process of adipose tissue
development through the extension of the capillary network and in
the genesis of obesity-associated cardiovascular pathologies through
their production of the metalloproteinase-9,29 a key enzyme in-
volved in cardiac remodeling processes.30 Accordingly, we show
that also abdominal subcutaneous adipose tissue appears to be
associated with both chronic inflammation and heart dysfunction.
Therefore, abdominal subcutaneous adipose tissue may be not
simply an inert storage deposit for lipids, but may represent an
important endocrine organ regulating whole-body metabolism
and other vital functions related to inflammation and immune
responses that have previously been ascribed only to visceral
adipose tissue.
The results obtained after dermolipectomy in obese women
also support a role for subcutaneous fat as a key factor predisposing
toward cardiac dysfunction, possibly through inappropriate cytokine
secretion. In fact, at the same level of body weight reduction, women
subjected to massive excision of abdominal fat cells had the greatest
decrease of cytokine levels and the greatest improvement of cardiac
functions 2 months after the abdominoplastic surgery compared with
women treated with diet program. Thus, the improvement of cardiac
function in obese women was more marked in those who lost more
subcutaneous abdominal fat and was strictly associated with a
decrease in cytokine concentrations. Liposuction and abdomino-
plasty are the most frequently used methods to address obesity by
plastic surgery techniques. As far as liposuction is concerned,
contrasting data regarding the role of liposuction on insulin
resistance and pro-inflammatory markers have been reported.12
By contrast, in the present study we investigated the possible
beneficial effect of abdominoplastic surgery, an alternative and
safe method by which a reduction in abdominal fat is achieved
without an intensive surgical approach.31 Our data seem to
TABLE 3. Clinical Characteristics, Metabolic Profile and Cardiac Parameters Before and 60 d After Abdominoplastic Surgery
(Abdominoplasty Group) and After Diet (Diet Group)
Abdominoplasty Group Diet Group
Before After 60 d P Before After 60 d P
n 20 20 — 28 28 —
Age (yr) 40  4 — 41  5 — —
BMI (kg/m2) 33.8  2.8 32.2  0.9 0.021 33.7  3.2 32.4  1.1 0.047
WHR 0.90  0.01 0.87  0.02* 0.001 0.90  0.02 0.89  0.04 0.242
Fasting glucose (mmol/L) 5.3  0.3 5.2  0.2 0.222 5.3  0.4 5.2  0.1 0,285
Fasting insulin (U/mL) 16.6  4.7 13.4  5.1 0.046 16.9  4.6 14.0  4.9 0.026
HOMA 3.6  0.5 2.8  0.7 0.013 3.5  0.4 2.9  0.5 0.016
Cholesterol (mmol/L) 5.1  0.5 5.0  0.6 0.570 5.1  0.4 5.1  0.2 0.845
LDL cholesterol (mmol/L) 3.0  0.2 3.0  0.4 0.987 3.1  0.1 3.0  0.3 0.165
HDL cholesterol (mmol/L) 1.1  0.2 1.2  0.3 0.222 1.1  0.3 1.1  0.4 0.898
Triglyceride (mmol/L) 1.4  0.3 1.2  0.1 0.006 1.5  0.3 1.3  0.2 0.005
TNF- (pg/mL) 6.0  1.7 4.3  1.6* 0.002 6.1  1.8 5.9  2.1 0.703
IL-6 (pg/mL) 4.1  0.6 2.9  0.9* 0.001 4.2  0.9 3.9  1.2 0.295
MPI 0.57  0.06 0.43  0.08* 0.001 0.56  0.04 0.54  0.06 0.148
Ejection fraction (%) 51  4 56  3* 0.001 50  6 53  6 0.067
Data are as means  SD.
*P  0.05 compared with diet group.
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indicate that abdominoplasty is more useful than liposuction in
cardiac function and lowering pro-inflammatory markers. The
differences between liposuction and abdominoplastic surgery
might be found in the possibility that abdominoplasty may
remove a larger amount of abdominal fat than liposuction, and
thus have a greater lowering effect on tissue release from ab-
dominal fat.
In conclusion, our study demonstrates that, in obese patients,
abdominoplastic surgery is associated with weight loss, improved
cardiac function and a lower degree of inflammation. Because of the
particular goal of the abdominoplasty, our study was carried out only
in women and we acknowledge that this could be a potential
limitation of our study. Thus, further long-term studies will be
needed to confirm our finding in a larger population (also including
men) and to determine if the cardiac effect of abdominoplastic
surgery will translate into a reduced incidence of cardiovascular
disease.
FIGURE 2. Representative immuno-
histochemical analysis of macro-
phages (CD68), interleukin-6 and
tumor necrosis factor (TNF)- from
subcutaneous adipose tissue speci-
mens of obese women undergoing
to abdominoplastic surgery (600)
(A). Correlations between myocar-
dial performace index and adipose
tissue levels of CD68, TNF- and
interleukin-6 (B).
TABLE 4. Relationships Between the Anthropometric
Changes After Abdominoplastic Surgery and Proinflammatory
Cytokines and Echocardiographic Parameters
BMI WHR
TNF-* 0.18 0.33†
IL-6* 0.20 0.42‡
HOMA 0.30§ 0.51‡
Ejection fraction 0.11 0.31†
MPI 0.10 0.37†
*Log transformed.
†P  0.02.
‡P  0.01.
§P  0.05.
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